Skip to main content

Site notifications

NARDIL phenelzine sulfate tablets USP, 15mg (Canada)

Section 19A approved medicine
NARDIL phenelzine sulfate tablets USP, 15mg (Canada)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN: 92 124 728 892
Phone
1300 788 261
Approved until
Status
Current
Medicines in short supply/unavailable
NARDIL phenelzine 15mg (as sulfate) tablet bottle - ARTG 93600
Indication(s)

For the treatment of major depression.

Phenelzine sulfate should rarely be the first antidepressant drug used. Rather it is more suitable for use with patients who have failed to respond to the drugs more commonly used for these conditions.

Images
Picture of NARDIL phenelzine sulfate tablets USP, 15mg (Canada)

Help us improve the Therapeutic Goods Administration site